Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/103850
Title: | Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link? | Authors: | Melo, Miguel Gavina, Cristina Silva-Nunes, José Andrade, Luís Carvalho, Davide |
Keywords: | Antidiabetic drug; GLP-1 RA; Cardiovascular disease; Cardiovascular outcome trials; Type 2 diabetes | Issue Date: | 27-Jul-2021 | Publisher: | Springer Nature | Serial title, monograph or event: | Diabetology and Metabolic Syndrome | Volume: | 13 | Issue: | 1 | Abstract: | Atherosclerotic cardiovascular diseases are the leading cause of adverse outcomes in patients with type 2 diabetes, and all new anti-diabetic agents are mandated to undergo cardiovascular outcome trials (CVOTs). Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are incretin mimetics that reduce blood glucose levels with a low associated risk of hypoglycaemia. CVOTs with different GLP-1 RAs yielded different results in terms of major cardiovascular composite outcome (MACE), with some trials showing superiority in the treatment arm, whereas other simply displayed non-inferiority. More importantly, the significance of each component of MACE varied between drugs. This begs the question of whether these differences are due to dissimilarities between drugs or other factors, namely trial design, are at the root of these differences. We analyse the trial designs for all CVOTs with GLP-1 RAs and highlight important differences between them, namely in terms of definition of established cardiovascular disease, and discuss how these differences might explain the disparate results of the trials and preclude direct comparisons between them. We conclude that a fair comparison between GLP-1 RA CVOTs would involve post-hoc analysis re-grouping the patients into different cardiovascular risk categories based upon their baseline clinical parameters, in order to even out the criteria used to classify patients. | URI: | https://hdl.handle.net/10316/103850 | ISSN: | 1758-5996 | DOI: | 10.1186/s13098-021-00698-5 | Rights: | openAccess |
Appears in Collections: | FMUC Medicina - Artigos em Revistas Internacionais |
Files in This Item:
Page view(s)
134
checked on Sep 25, 2024
Download(s)
95
checked on Sep 25, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License